Racial and ethnic minorities, older adults, rural residents, and individuals of low
socioeconomic status are underrepresented among participants in cancer‐related trials. The …

Cancer is primarily a disease of the elderly. Greater than 60% of new cancers occur in
people aged> 65 years, and 60% of the current 10 million cancer survivors are aged≥ 65 …

BACKGROUND The aim was to identify age‐related and gender‐related differences in the
clinical presentation and outcome of patients with primary cutaneous melanoma (CM) …

The cornerstone of treatment for rectal cancer is resectional treatment according to the
principles of total mesorectal excision (TME). However, population-based registries show …

Purpose National Cancer Institute of Canada Clinical Trials Group Study BR. 21 established
erlotinib as a standard of care in patients with non–small-cell lung cancer (NSCLC) after …

Background. This study was performed to describe the treatment plan modifications after a
geriatric oncology clinic. Assessment of health and functional status and cancer assessment …

This randomised multicentre phase II study was conducted to investigate the activity and
safety of two oral fluoropyrimidines, capecitabine or S-1, in elderly patients with advanced …

Abstract Treatment of adults with acute myeloblastic leukemia has changed substantially
over the past two decades. Currently available estimates of survival do not reflect results …

The incidence of malignant pleural mesothelioma (MPM) in elderly patients is increasing. In
this study, pooled data from two phase II trials of pemetrexed and carboplatin (PC) as first …

Purpose To determine the impact of age and health status on adjuvant treatment
recommendations for older patients with breast cancer from the perspective of medical …